← Leaderboards
Catherine T Flores
University Of Florida
$4,894,915
Attributed
$8,343,736
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2019–24$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,343,736 · 4
By mechanism
U01$4,598,428 · 1
R01$3,325,933 · 2
R21$419,375 · 1
Top collaborators
- Albert Sidney Baldwin4 shared
- Scott R Floyd4 shared
- Shawn Hingtgen4 shared
Most similar at University Of Florida
Same institution · by research overlap
- Brad H. Pollock$62,738,731
- Ronald L Davis$43,827,828
- Bryon E Petersen$7,531,216
- Connor Patrick Francis$233,985
- Philip J Scarpace$5,681,848
Others in their field
Other Emerging Leaders on “Brain Neoplasms”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Greg Yothers · University Of Chicago$35,003,821
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Crystal Mackall · Children'S Hosp Of Philadelphia$13,823,781
- Olwen Hahn · Brigham And Women'S Hospital$13,557,463
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
Research focus
Brain NeoplasmsClinical ResearchMalignant Neoplasm Of BrainImmunotherapyTumor HeterogeneityCellsPathway InteractionsImmuneGlioblastomaCell TherapyGliomaAntigensSolid NeoplasmRecurrenceT-LymphocyteMedulloblastomaPre-Clinical ModelTumorDendritic CellsCheckpoint InhibitionInterferon Type IiBone MarrowImmune SystemMalignant Glioma
Grant awards (15)
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,117,537
U01 · FY2024 · TR
Hematopoietic stem cells overcome treatment resistance to PD-1 blockade against brain tumors$323,587
R01 · FY2024 · NS · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,135,383
U01 · FY2023 · TR
Developmentally regulated antigens for immunologic targeting of pediatric brain tumors$419,375
R21 · FY2023 · NS · contact PI
Hematopoietic stem cells overcome treatment resistance to PD-1 blockade against brain tumors$333,594
R01 · FY2023 · NS · contact PI
Hematopoietic stem cells overcome treatment resistance to adoptive cellular therapy against malignant gliomas$333,594
R01 · FY2023 · NS · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,150,319
U01 · FY2022 · TR
Hematopoietic stem cells overcome treatment resistance to PD-1 blockade against brain tumors$333,594
R01 · FY2022 · NS · contact PI
Hematopoietic stem cells overcome treatment resistance to adoptive cellular therapy against malignant gliomas$333,594
R01 · FY2022 · NS · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,195,189
U01 · FY2021 · TR
Hematopoietic stem cells overcome treatment resistance to PD-1 blockade against brain tumors$333,594
R01 · FY2021 · NS · contact PI
Hematopoietic stem cells overcome treatment resistance to adoptive cellular therapy against malignant gliomas$333,594
R01 · FY2021 · NS · contact PI
Hematopoietic stem cells overcome treatment resistance to adoptive cellular therapy against malignant gliomas$333,594
R01 · FY2020 · NS · contact PI
Hematopoietic stem cells overcome treatment resistance to PD-1 blockade against brain tumors$333,594
R01 · FY2020 · NS · contact PI
Hematopoietic stem cells overcome treatment resistance to adoptive cellular therapy against malignant gliomas$333,594
R01 · FY2019 · NS · contact PI